Correlation Between CRISPR Therapeutics and FIRST NATIONAL
Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and FIRST NATIONAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and FIRST NATIONAL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CRISPR Therapeutics AG and FIRST NATIONAL FIN, you can compare the effects of market volatilities on CRISPR Therapeutics and FIRST NATIONAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of FIRST NATIONAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and FIRST NATIONAL.
Diversification Opportunities for CRISPR Therapeutics and FIRST NATIONAL
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between CRISPR and FIRST is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and FIRST NATIONAL FIN in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FIRST NATIONAL FIN and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with FIRST NATIONAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FIRST NATIONAL FIN has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and FIRST NATIONAL go up and down completely randomly.
Pair Corralation between CRISPR Therapeutics and FIRST NATIONAL
If you would invest 2,110 in FIRST NATIONAL FIN on October 11, 2024 and sell it today you would earn a total of 510.00 from holding FIRST NATIONAL FIN or generate 24.17% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
CRISPR Therapeutics AG vs. FIRST NATIONAL FIN
Performance |
Timeline |
CRISPR Therapeutics |
FIRST NATIONAL FIN |
CRISPR Therapeutics and FIRST NATIONAL Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CRISPR Therapeutics and FIRST NATIONAL
The main advantage of trading using opposite CRISPR Therapeutics and FIRST NATIONAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, FIRST NATIONAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FIRST NATIONAL will offset losses from the drop in FIRST NATIONAL's long position.CRISPR Therapeutics vs. CDN IMPERIAL BANK | CRISPR Therapeutics vs. Cincinnati Financial Corp | CRISPR Therapeutics vs. Corporate Office Properties | CRISPR Therapeutics vs. REVO INSURANCE SPA |
FIRST NATIONAL vs. CARSALESCOM | FIRST NATIONAL vs. ecotel communication ag | FIRST NATIONAL vs. INFORMATION SVC GRP | FIRST NATIONAL vs. CRISPR Therapeutics AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |